PAPER Gerben SR, Lemkul JA, Brown AM, Bevan DR
SEARCH RESULTS
330986 RESULTS
PAPER Fossati S, Todd K, Sotolongo K, Ghiso J, Rostagno A
Differential contribution of isoaspartate post-translational modifications to the fibrillization and toxic properties of amyloid-β and the asparagine 23 Iowa mutation.
Biochem J. 2013 Dec 15;456(3):347-60. PubMed: 24028142PAPER Bandopadhyay R, Liu JY, Sisodiya SM, Thom M
A Comparative Study of the Dentate Gyrus in Hippocampal Sclerosis in Epilepsy and Dementia.
Neuropathol Appl Neurobiol. 2013 Sep 12; PubMed: 24028428PAPER Kalaria DR, Patel P, Merino V, Patravale VB, Kalia YN
CONTROLLED IONTOPHORETIC TRANSPORT OF HUPERZINE A ACROSS SKIN IN VITRO AND IN VIVO: EFFECT OF DELIVERY CONDITIONS AND COMPARISON OF PHARMACOKINETIC MODELS.
Mol Pharm. 2013 Sep 30; PubMed: 24028565PAPER Foolad F, Khodagholi F
Dietary supplementation with Salvia sahendica attenuates acetylcholinesterase activity and increases mitochondrial transcription factor A and antioxidant proteins in the hippocampus of amyloid beta-injected rats.
J Pharm Pharmacol. 2013 Oct;65(10):1555-62. PubMed: 24028623PAPER Schmitz M, Wulf K, Signore SC, Schulz-Schaeffer WJ, Kermer P, Bähr M, Wouters FS, Zafar S, Zerr I
Impact of the Cellular Prion Protein on Amyloid-β and 3PO-Tau Processing.
J Alzheimers Dis. 2014 Jan 1;38(3):551-65. PubMed: 24028865PAPER Ren Y, Lin WL, Sanchez L, Ceballos C, Polydoro M, Spires-Jones TL, Hyman BT, Dickson DW, Sahara N
Endogenous Tau Aggregates in Oligodendrocytes of rTg4510 Mice Induced by Human P301L Tau.
J Alzheimers Dis. 2014 Jan 1;38(3):589-600. PubMed: 24028867PAPER Lundström SL, Yang H, Lyutvinskiy Y, Rutishauser D, Herukka SK, Soininen H, Zubarev RA
Blood Plasma IgG Fc Glycans are Significantly Altered in Alzheimer's Disease and Progressive Mild Cognitive Impairment.
J Alzheimers Dis. 2014 Jan 1;38(3):567-79. PubMed: 24028868PAPER Payne AJ, Gerdes BC, Naumchuk Y, McCalley AE, Kaja S, Koulen P
Presenilins regulate the cellular activity of ryanodine receptors differentially through isotype-specific N-terminal cysteines.
Exp Neurol. 2013 Dec;250:143-50. PubMed: 24029002PAPER Canas PM, Simões AP, Rodrigues RJ, Cunha RA
Predominant loss of glutamatergic terminal markers in a β-amyloid peptide model of Alzheimer's disease.
Neuropharmacology. 2014 Jan;76 Pt A:51-6. PubMed: 24029236PAPER Braskie MN, Thompson PM
Understanding cognitive deficits in Alzheimer's disease based on neuroimaging findings.
Trends Cogn Sci. 2013 Oct;17(10):510-6. PubMed: 24029445PAPER Voss MW, Vivar C, Kramer AF, van Praag H
Bridging animal and human models of exercise-induced brain plasticity.
Trends Cogn Sci. 2013 Oct;17(10):525-44. PubMed: 24029446PAPER Mufson EJ, Ward S, Binder L
Prefibrillar Tau Oligomers in Mild Cognitive Impairment and Alzheimer's Disease.
Neurodegener Dis. 2013 Sep 11; PubMed: 24029627PAPER van Rooden S, Goos JD, van Opstal AM, Versluis MJ, Webb AG, Blauw GJ, van der Flier WM, Scheltens P, Barkhof F, van Buchem MA, van der Grond J
Increased Number of Microinfarcts in Alzheimer Disease at 7-T MR Imaging.
Radiology. 2013 Sep 12; PubMed: 24029643PAPER Sigurdsson EM
Tau immunotherapy and imaging.
Neurodegener Dis. 2014;13(2-3):103-6. Epub 2013 Sep 11 PubMed: 24029727Current Filters
No filters selected